既往诊断多囊卵巢综合征(以高雄激素表型为主)女性单胎妊娠并发症发生率升高
前瞻性多中心队列研究纳入188例多囊卵巢综合征(PCOS)单胎妊娠孕妇与2889例自然受孕单胎孕妇,PCOS组妊娠期糖尿病(AOR 4.15;95%CI 2.07-8.33)及小于胎龄儿(AOR 3.76;95%CI 1.69-8.35)风险显著升高;高雄激素表型者母体并发症发生率高于正常雄激素表型者(45% vs 24%;P=.003)。
要点
- PCOS孕妇妊娠期糖尿病风险升高(AOR 4.15;95%CI 2.07-8.33)。
- PCOS孕妇小于胎龄儿风险升高(AOR 3.76;95%CI 1.69-8.35)。
- 高雄激素表型PCOS母体并发症发生率45% vs 正常雄激素表型24%(P=.003)。
核心结论
- PCOS女性母体及新生儿妊娠并发症风险升高,高雄激素表型者尤为明显。
研究设计与样本
- 前瞻性多中心队列研究,PCOS单胎妊娠孕妇188例(研究组),自然受孕单胎妊娠孕妇2889例(参照组)。
- 观察性研究,未设干预。
- 临床试验注册号NCT00821379。
主要发现
- PCOS组妊娠期糖尿病风险较参照组显著升高(AOR 4.15;95%CI 2.07-8.33)。
- PCOS组小于胎龄儿风险较参照组显著升高(AOR 3.76;95%CI 1.69-8.35)。
- 亚组分析中,高雄激素表型(游离雄激素指数>4.5)PCOS孕妇(n=76,占全部PCOS的40%)母体并发症发生率45%,正常雄激素表型PCOS孕妇(n=97,占全部PCOS的52%)为24%,两组差异有统计学意义(P=.003)。
- 高雄激素表型与正常雄激素表型PCOS两组间新生儿并发症未见统计学显著差异。
关键数值与推荐
- 高雄激素表型定义为游离雄激素指数>4.5。
- 高雄激素表型PCOS孕妇占全部PCOS的40%(n=76),正常雄激素表型占52%(n=97)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the presence of several maternal and neonatal complications in a cohort of women with hyperandrogenic as well as normoandrogenic polycystic ovary syndrome (PCOS) and women with PCOS who received different fertility treatments. DESIGN: Prospective multicenter cohort study. SETTING: Hospitals and midwifery practices. PATIENT(S): One hundred and eighty-eight women with PCOS and singleton pregnancies (study group) and 2,889 women with a naturally conceived singleton pregnancy (reference group). INTERVENTION(S): Observational study. MAIN OUTCOME MEASURE(S): Maternal and neonatal pregnancy complications. RESULT(S): Women with PCOS had a statistically significantly increased risk of developing gestational diabetes (adjusted odds ratio [AOR] 4.15; 95% confidence interval [CI], 2.07-8.33) compared with the reference group, and their infants were more often born small for gestational age (AOR 3.76; 95% CI, 1.69-8.35). In a subgroup analysis, maternal complications were statistically significantly more often present in women with hyperandrogenic (defined as a free androgen index >4.5) PCOS (n = 76; 40% of all PCOS women) compared with those with normoandrogenic PCOS (n = 97; 52% of all PCOS women) (45% vs. 24%; P=.003); no statistically significant differences were observed between these groups regarding neonatal complications. CONCLUSION(S): Women with PCOS have an increased risk of maternal and neonatal pregnancy complications, especially women with the hyperandrogenic phenotype. CLINICAL TRIAL REGISTRATION NUMBER: NCT00821379.
引用
- de Wilde MA, Lamain-de Ruiter M, Veltman-Verhulst SM, et al. Increased rates of complications in singleton pregnancies of women previously diagnosed with polycystic ovary syndrome predominantly in the hyperandrogenic phenotype. Fertil Steril. 2017. PMID: 28778282. doi:10.1016/j.fertnstert.2017.06.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。